Lieveld Arthur W E, Kok Bram, Schuit Frederik H, Azijli Kaoutar, Heijmans Jarom, van Laarhoven Arjan, Assman Natascha L, Kootte Ruud S, Olgers Tycho J, Nanayakkara Prabath W B, Bosch Frank H
Section General and Acute Internal Medicine, Dept of Internal Medicine, Amsterdam Public Health Research Institute, Amsterdam UMC, location VUmc, Amsterdam, The Netherlands.
These authors contributed equally.
ERJ Open Res. 2020 Dec 21;6(4). doi: 10.1183/23120541.00539-2020. eCollection 2020 Oct.
In this coronavirus disease 2019 (COVID-19) pandemic, fast and accurate testing is needed to profile patients at the emergency department (ED) and efficiently allocate resources. Chest imaging has been considered in COVID-19 workup, but evidence on lung ultrasound (LUS) is sparse. We therefore aimed to assess and compare the diagnostic accuracy of LUS and computed tomography (CT) in suspected COVID-19 patients.
This multicentre, prospective, observational study included adult patients with suspected COVID-19 referred to internal medicine at the ED. We calculated diagnostic accuracy measures for LUS and CT using both PCR and multidisciplinary team (MDT) diagnosis as reference. We also assessed agreement between LUS and CT, and between sonographers.
One hundred and eighty-seven patients were recruited between March 19 and May 4, 2020. Area under the receiver operating characteristic (AUROC) was 0.81 (95% CI 0.75-0.88) for LUS and 0.89 (95% CI 0.84-0.94) for CT. Sensitivity and specificity for LUS were 91.9% (95% CI 84.0-96.7) and 71.0% (95% CI 61.1-79.6), respectively, 88.4% (95% CI 79.7-94.3) and 82.0% (95% CI 73.1-89.0) for CT. Negative likelihood ratio was 0.1 (95% CI 0.06-0.24) for LUS and 0.14 (95% CI 0.08-0.3) for CT. No patient with a false negative LUS required supplemental oxygen or admission. LUS specificity increased to 80% (95% CI 69.9-87.9) compared to MDT diagnosis, with an AUROC of 0.85 (95% CI 0.79-0.91). Agreement between LUS and CT was 0.65. Interobserver agreement for LUS was good: 0.89 (95% CI 0.83-0.93).
LUS and CT have comparable diagnostic accuracy for COVID-19 pneumonia. LUS can safely exclude clinically relevant COVID-19 pneumonia and may aid COVID-19 diagnosis in high prevalence situations.
在2019冠状病毒病(COVID-19)大流行期间,需要快速准确的检测来对急诊科(ED)的患者进行评估,并有效分配资源。胸部成像已被纳入COVID-19的检查流程,但关于肺部超声(LUS)的证据较少。因此,我们旨在评估和比较LUS与计算机断层扫描(CT)在疑似COVID-19患者中的诊断准确性。
这项多中心、前瞻性、观察性研究纳入了在急诊科内科就诊的疑似COVID-19成年患者。我们以聚合酶链反应(PCR)和多学科团队(MDT)诊断作为参考,计算LUS和CT的诊断准确性指标。我们还评估了LUS与CT之间以及超声检查人员之间的一致性。
2020年3月19日至5月4日期间招募了187例患者。LUS的受试者操作特征曲线下面积(AUROC)为0.81(95%可信区间0.75-0.88),CT为0.89(95%可信区间0.84-0.94)。LUS的敏感性和特异性分别为91.9%(95%可信区间84.0-96.7)和71.0%(95%可信区间61.1-79.6),CT分别为88.4%(95%可信区间79.7-94.3)和82.0%(95%可信区间73.1-89.0)。LUS的阴性似然比为0.1(95%可信区间0.06-0.24),CT为0.14(95%可信区间0.08-0.3)。LUS检查结果为假阴性的患者均无需补充氧气或住院治疗。与MDT诊断相比,LUS的特异性提高到80%(95%可信区间69.9-87.9),AUROC为0.85(95%可信区间0.79-0.91)。LUS与CT之间的一致性为0.65。LUS的观察者间一致性良好:0.89(95%可信区间0.83-0.93)。
LUS和CT对COVID-19肺炎具有相当的诊断准确性。LUS可以安全地排除具有临床意义的COVID-19肺炎,并且在高流行情况下可能有助于COVID-19的诊断。